A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis - IM0271015
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis - IM027068
100 Clinical Results associated with Bristol-Myers Squibb Manufacturing Company Unlimited Co.
0 Patents (Medical) associated with Bristol-Myers Squibb Manufacturing Company Unlimited Co.
100 Deals associated with Bristol-Myers Squibb Manufacturing Company Unlimited Co.
100 Translational Medicine associated with Bristol-Myers Squibb Manufacturing Company Unlimited Co.